DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2001 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: NEXIUM

Summary for Tradename: NEXIUM

Patents:16
Applicants:1
NDAs:1
Suppliers: see list11
2013 Sales:$6,135,667,000
drug
patent expirations by year for
 NEXIUM

Pharmacology for Tradename: NEXIUM

Clinical Trials for: NEXIUM

Nexium Study To Suppress Nausea During Chemotherapy
Status: Terminated Condition: Nausea

The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Status: Completed Condition: Type 2 Diabetes

Viokase 16, Viokase16 Plus Nexium and Nexium Alone
Status: Terminated Condition: Chronic Pancreatitis

Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers
Status: Completed Condition: Healthy

A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Status: Completed Condition: Arthritis

Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
Status: Completed Condition: Gastroesophageal Reflux Disease

Prevention of Gastric Ulcers
Status: Completed Condition: NSAID Associated Gastric Ulcers

Ulcer Prevention II
Status: Completed Condition: NSAID Associated Gastric Ulcers

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately
Status: Completed Condition: Peptic Ulcer Disease

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
Status: Completed Condition: NSAID Associated Gastric Ulcers

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Astrazeneca
NEXIUM
esomeprazole magnesium
Capsule, Delayed Rel Pellets; Oral021153FEB 20, 2001RXYes<disabled><disabled>
Astrazeneca
NEXIUM
esomeprazole magnesium
Capsule, Delayed Rel Pellets; Oral021153FEB 20, 2001RXYes4,255,431<disabled><disabled>
Astrazeneca
NEXIUM
esomeprazole magnesium
Capsule, Delayed Rel Pellets; Oral021153FEB 20, 2001RXYes4,508,905<disabled><disabled>
Astrazeneca
NEXIUM
esomeprazole magnesium
Capsule, Delayed Rel Pellets; Oral021153FEB 20, 2001RXYes4,636,499<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NEXIUM

Drugname Dosage Strength RLD Submissiondate
esomeprazole sodiumFor Injection20 mg/vial and 40 mg/vialNexium IV11/23/2009
esomeprazole magnesiumDelayed-release20 mg and 40 mgNexium8/5/2005

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc